Latest News

Key Insights Institutions' substantial holdings in Bega Cheese implies that they have significant influence over the...

Earlier this month, FinVolution Group hosted a closed-door technology forum titled "New AI Paradigms: The Core Logic Driving Future Development," where it gathered over 20 leading AI scholars and unveiled an AI framework that blends commercial and proprietary models to strengthen risk management and customer service. The company also flagged an upcoming white paper on embedding multimodal large models into cross-border fintech operations, highlighting how AI could reshape its international...

The board of APA Group ( ASX:APA ) has announced that it will pay a dividend of A$0.275 per share on the 18th of March...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...

Accenture (ACN) opened fiscal 2026 with Q1 revenue of about $18.7 billion and basic EPS of $3.57, setting the tone for another year where profit growth is firmly in focus. The company has seen quarterly revenue move from roughly $16.4 billion in Q4 2024 to $18.7 billion in Q1 2026, while basic EPS has ranged between about $2.27 and $3.64 over that stretch. This gives investors a clear view of how top line and per share earnings have been tracking. With trailing net margins easing a touch and...

Cresco Labs recently welcomed the U.S. federal government’s move to reschedule cannabis from Schedule I to Schedule III, calling it a historic policy shift for the regulated cannabis industry. The company highlighted that rescheduling could ease tax burdens, improve access to banking and research, and further legitimize state-regulated cannabis markets, directly supporting its brand-building and expansion efforts. We’ll now examine how easing federal tax burdens and banking frictions could...

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...

We wouldn't blame Energy Services of America Corporation ( NASDAQ:ESOA ) shareholders if they were a little worried...

If you are wondering whether EchoStar’s explosive run still has room to continue, or if the market has already priced in the story, you are not alone. This is exactly where a closer look at valuation comes in. After a massive 350.9% year to date gain and 353.7% rise over the last year, the stock has recently cooled off a bit, with a 1.7% pullback over the past week. This could signal either a healthy breather or early profit taking. Recent headlines have focused on EchoStar’s strategic...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

MiMedx Group recently published new peer-reviewed data in the Journal of Inflammation showing that its Purion-processed DHACM and LHACM placental allografts exert multifactorial immunomodulatory effects on key inflammatory cells involved in wound healing. The findings that these allografts both temper inflammatory monocyte and macrophage activity and enhance pro-reparative functions such as efferocytosis and cell survival could strengthen the medical community’s confidence in MiMedx’s...

As the U.S. stock market experiences a resurgence, with major indices like the Nasdaq and S&P 500 seeing notable gains driven by tech shares, investors are keenly observing opportunities that may arise from these fluctuations. In such an environment, identifying undervalued stocks can be crucial for those looking to capitalize on potential growth while maintaining a balanced portfolio amidst shifting market dynamics.

As the U.S. stock market experiences a surge, particularly in tech shares, investors are closely monitoring growth companies with high insider ownership as potential opportunities amidst this renewed risk appetite. In such an environment, stocks that combine robust earnings growth with significant insider stakes can offer insights into management confidence and alignment with shareholder interests.

Major stock indexes in the United States have recently experienced a surge, driven by gains in technology shares and positive economic indicators. While the term "penny stocks" might seem outdated, it still refers to shares of smaller or newer companies that can offer significant potential for growth. By focusing on those with solid financial foundations, investors can uncover opportunities that may provide stability and upside potential.

As the U.S. market navigates a landscape marked by surging tech shares and volatile index movements, investors are keenly observing how these dynamics impact small-cap stocks, particularly within the S&P 600. With major indices like the Nasdaq and S&P 500 experiencing gains driven by AI-related optimism, identifying lesser-known stocks with strong fundamentals can be key to capitalizing on potential growth opportunities amidst broader market shifts.

As the U.S. stock market experiences a resurgence, with major indexes like the Nasdaq and S&P 500 seeing notable gains driven by tech shares, investors are keenly observing opportunities across various sectors. In this dynamic environment, dividend stocks stand out as a compelling option for those seeking consistent income streams alongside potential capital appreciation.

Earlier this week, SLR Credit Solutions closed a US$100 million senior secured term loan for The Children’s Place, alongside a US$350 million revolving credit facility from Wells Fargo, bolstering the retailer’s liquidity after using proceeds to repay existing borrowings and fund future initiatives. This financing arrives just after The Children’s Place reported its third consecutive quarterly loss and a 13% year-on-year sales decline, underlining the tension between its funding needs and...

Birkenstock Holding (BIRK) closed FY 2025 with fourth quarter revenue of €526 million and EPS of €0.51, alongside net income of €93.9 million. This result underscores another solid print on the back of a strong year of demand for its core footwear franchise. The company has seen revenue move from €456 million and EPS of €0.28 in Q4 FY 2024 to €526 million and €0.51 in Q4 FY 2025, while trailing 12 month revenue reached about €2.1 billion and EPS hit €1.87, giving investors a clear view of...

ZenaTech (ZENA) is back on traders radar after updating plans for its Baton Rouge Zena AI R&D center, a new hub for defense focused AI and quantum driven systems opening in early 2026. See our latest analysis for ZenaTech. The Baton Rouge update comes after a string of defense focused calls, drone partnership progress and the UK Casado Design acquisition. The stock’s sharp 1 day share price return of 15.4 percent contrasts with a much weaker year to date share price return and a deeply...

AMC Robotics (AMCI) has grabbed fresh attention after unveiling a non binding supplier framework with a Japanese government agency to roll out its quadruped robotics platform, linking future growth prospects to overseas public sector demand. See our latest analysis for AMC Robotics. The supplier framework news lands after a whirlwind debut, with AMC Robotics completing its SPAC merger, joining the Nasdaq Composite, and trading through sharp swings that left the latest share price at $10.16...

For investors wondering whether ESCO Technologies at around $198 a share is still attractive or already priced for perfection, it is exactly the kind of stock where valuation really matters. Even after a strong run, with the stock up 50.6% year to date and 46.7% over the last year, the recent pullback of 3.0% over 7 days and 8.7% over 30 days suggests investors are reassessing the risk-reward trade-off. Those swings have come as the market focuses more on industrial names tied to long-term...

Rezolute, Inc. recently reported topline Phase 3 sunRIZE results for ersodetug in congenital hyperinsulinism, with the trial failing to meet its primary and key secondary endpoints and showing some safety concerns, including rare serious hypersensitivity reactions. Despite the missed endpoints, the highest ersodetug dose produced a hypoglycemia reduction similar to placebo and the company continues to advance the related upLIFT Phase 3 study in tumor-induced hyperinsulinism, highlighting...

Nordson (NDSN) has just wrapped up FY 2025 with fourth quarter revenue of $751.8 million and EPS of $2.70, capping off a year where trailing 12 month revenue reached about $2.8 billion and EPS came in at $8.56. The company has seen quarterly revenue move from $615.4 million in Q1 2025 to $751.8 million in Q4, while EPS stepped up from $1.66 to $2.70 over the same stretch. This sets the stage for investors to focus on how durable these margins look heading into the next financial year. See our...

Synovus Financial (SNV) has been quietly grinding higher, and the stock’s recent move reflects a market that is starting to reprice its steady growth in both revenue and earnings. Investors are paying attention. See our latest analysis for Synovus Financial. At around $52.25 per share, Synovus has cooled slightly after a strong recent run. However, a 30 day share price return of 13.51% and a robust multi year total shareholder return suggest momentum is broadly still building as investors...